Neuronetics Inc (STIM) stock price

Neuronetics Inc (STIM) is a Healthcare · Medical Devices company listed on NASDAQ. Price $2.94 (-1.01%), Market cap $0.08B, 52-week low–high $1.18 ~ $4.66.

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to ex

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Neuronetics Inc are updated in real time on BlackAll Trade.

Neuronetics Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Neuronetics Inc (STIM) stock price?

Neuronetics Inc trades at $2.94 (-1.01%). Real-time quotes and charts are available on BlackAll Trade.

What is the Neuronetics Inc (STIM) market cap?

Neuronetics Inc has a market cap of about $0.08B.

What does Neuronetics Inc (STIM) do?

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a